Wed, Oct 22, 2014, 10:04 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Dec 9, 2012 10:24 AM Flag

    Pfizer portfolio update

    12/31/10 - 262,215 - ($17.51) Year-end 2010 close
    12/31/11 - 481,195 - ($21.64) Year-end 2011 close

    01/03 - 488,645 - ($21.97) RSI 69.5
    01/12 - 501,920 - ($21.99) RSI 65.8
    02/01 - 488,525 - ($21.31) Ex-dividend 22 cents, RSI 47.1
    02/06 - 471,285 - ($20.95) 2012 valuation low, RSI 43.4
    03/30 - 555,110 - ($22.65) RSI 72.9, an interim 2012 high
    04/13 - 527,300 - ($21.85) 9 straight losing sessions, RSI 45.4
    04/27 - 577,965 - ($23.08) RSI 70.0
    05/04 - 555,335 - ($22.38) RSI 47.7
    05/09 - 559,605 - ($22.45) Ex-dividend 22 cents, RSI 56.3
    05/10 - 574,430 - ($22.83) Tofacitinib recommended, RSI 64.0
    06/05 - 524,015 - ($21.60) RSI 33.6, lowest in ten months
    07/02 - 604,505 - ($23.00) RSI 65.6
    07/11 - 576,620 - ($22.34) RSI 45.5
    07/19 - 633,095 - ($23.80) RSI 72.2
    07/25 - 616,455 - ($23.33) RSI 58.6
    07/27 - 639,325 - ($23.83) RSI 67.0
    08/01 - 638,820 - ($23.94) Ex-dividend 22 cents, RSI 70.1
    08/03 - 650,580 - ($24.28) RSI 73.9
    08/07 - 641.145 - ($23.74) Bapi fails, RSI 59.0
    08/15 - 652,925 - ($24.04) RSI 62.1
    08/21 - 644,640 - ($23.69) RSI 52.1
    09/13 - 672,300 - ($24.25) RSI 59.6
    09/14 - 658,780 - ($23.80) RSI 47.8
    10/18 - 710,540 - ($26.04) RSI 76.2, Highest since Q3-06
    11/06 - 680,760 - ($24.78) RSI 43.3, Election Day
    11/07 - 654,695 - ($24.17) Ex-dividend 22 cents, RSI 38.1)
    11/15 - 632,975 - ($23.66) RSI 30.0, Lowest in 15 months
    11/30 - 703,070 - ($25.02) RSI 61.5
    12/05 - 723,890 - ($25.64) All-time valuation high, RSI 70.5)
    12/07 - 720,935 - ($25.56) RSI 68.2



    Up 49.3%. 2012 Portfolio gain to date based on $239,740 valuation increase less $2,850 interest
    Up 41.1%. 2012 Portfolio gain to date based on return on invested capital
    Up 22.2%. 2012 Pfizer stock price gain to date including four 22-cent dividends

    Up 12.7%. S & P 500 gain to date (1,258 to 1,418)



    Note: This portfolio had a steady cost basis of $100,000 from 11/17/04 inception through 6/2/08. From that date through mid-March of 2009, additional funds were invested until the cost basis reached $296,110. The basis has remained steady again since that time.

    Note: This portfolio was up by as much as 96K pre-crash on 6/1/07 with the stock closing at $27.68 that day. It was also down as much as 333K on 3/2/09 when the stock closed at $11.66. Gains of 428K from inception were seen on 12/05/12 with the stock at $25.64. Current gains are 425K.

    Note: Over time, the leverage factor at these portfolio levels is about 1.9, the lowest since inception. It was designed at the end of 2011 to go up by about 59K per Pfizer point up to $25 on the stock and then 53K a point thereafter. .

    Note: Average annualized gains from inception stands at 11.5% and considers all additional funds needed to margin the naked puts.

    Sentiment: Buy

 
PFE
28.30+0.02(+0.07%)Oct 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yelp, Inc.
NYSEWed, Oct 22, 2014 4:00 PM EDT
NXP Semiconductors NV
NasdaqGSWed, Oct 22, 2014 4:00 PM EDT
Herbalife Ltd.
NYSEWed, Oct 22, 2014 4:00 PM EDT